다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (VIR) 뉴스

VIR

Vir Biotechnology (VIR)

Vir Biotechnology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VIR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VIR	Vir Biotechnology Inc
2024/05/03	05:05	Business Wire	Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results	NASDAQ:VIR	Vir Biotechnology Inc
2024/05/01	05:05	Business Wire	Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024	NASDAQ:VIR	Vir Biotechnology Inc
2024/04/18	21:00	Business Wire	Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors	NASDAQ:VIR	Vir Biotechnology Inc
2024/04/12	05:30	Business Wire	Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024	NASDAQ:VIR	Vir Biotechnology Inc
2024/03/05	22:05	Business Wire	Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	09:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	09:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	09:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	09:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	06:27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/27	06:10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/23	22:05	Business Wire	Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/23	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/23	06:05	Business Wire	Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/21	06:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/21	06:30	Business Wire	Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/17	08:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/14	07:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VIR	Vir Biotechnology Inc
2024/02/02	06:05	Business Wire	Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024	NASDAQ:VIR	Vir Biotechnology Inc
2024/01/04	04:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2023/12/14	19:59	IH Market News	Apple Stocks Reach Record, Adobe Faces Stock Drops, Berkshire Hathaway Increases Stake in OXY, and More	NASDAQ:VIR	Vir Biotechnology Inc
2023/12/14	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2023/12/14	06:05	Business Wire	Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation	NASDAQ:VIR	Vir Biotechnology Inc
2023/12/07	06:05	Business Wire	Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference	NASDAQ:VIR	Vir Biotechnology Inc
2023/11/13	22:00	Business Wire	Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023	NASDAQ:VIR	Vir Biotechnology Inc
2023/11/10	22:00	Business Wire	Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023	NASDAQ:VIR	Vir Biotechnology Inc
2023/11/08	22:05	Business Wire	Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™	NASDAQ:VIR	Vir Biotechnology Inc
2023/11/04	05:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2023/11/04	05:33	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:VIR	Vir Biotechnology Inc

검색 관련기사 보기:NASDAQ:VIR

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Yen

Invesco QQQ Trust Series 1

JP Morgan Chase

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관